Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000485789 | SCV000574085 | uncertain significance | not provided | 2024-02-22 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease (PMID: 22696272; HGMD); This variant is associated with the following publications: (PMID: 22696272) |
Labcorp Genetics |
RCV002230960 | SCV000631479 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313259 | SCV000738600 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-04-18 | criteria provided, single submitter | clinical testing | The p.P995T variant (also known as c.2983C>A), located in coding exon 38 of the COL5A1 gene, results from a C to A substitution at nucleotide position 2983. The proline at codon 995 is replaced by threonine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Mayo Clinic Laboratories, |
RCV000485789 | SCV004225173 | uncertain significance | not provided | 2023-06-13 | criteria provided, single submitter | clinical testing | BS1 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004701538 | SCV005205354 | likely benign | not specified | 2024-06-04 | criteria provided, single submitter | clinical testing |